European Medicines Agency recommends approval of Tafinlar for the treatment of metastatic melanoma

View source ↗

Summary

EMA recommends approval of Tafinlar (dabrafenib) for treating metastatic melanoma, indicating regulatory support for its use in this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• TAFINLAR (DABRAFENIB)